カテゴリー： Market Monitor Global, 世界, 医療/バイオ

フルオシノロンアセトニド硝子体内インプラントのグローバル市場展望 2023年-2029年：0.18mg、0.19mg、0.59mg

◆英語タイトル：Fluocinolone Acetonide Intravitreal Implant Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC14325）◆商品コード：MMG23DC14325
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月（※2025年版があります。お問い合わせください。）
◆ページ数：72
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥468,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥608,400見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥702,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のフルオシノロンアセトニド硝子体内インプラント市場規模と予測を収録しています。・世界のフルオシノロンアセトニド硝子体内インプラント市場：売上、2018年-2023年、2024年-2029年
・世界のフルオシノロンアセトニド硝子体内インプラント市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のフルオシノロンアセトニド硝子体内インプラント市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「0.18mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

フルオシノロンアセトニド硝子体内インプラントのグローバル主要企業は、Auxilium Pharma、 Bausch + Lomb、 EyePoint Pharmaceuticals、 OcuMensionなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、フルオシノロンアセトニド硝子体内インプラントのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のフルオシノロンアセトニド硝子体内インプラント市場：タイプ別、2018年-2023年、2024年-2029年
世界のフルオシノロンアセトニド硝子体内インプラント市場：タイプ別市場シェア、2022年
・0.18mg、0.19mg、0.59mg

世界のフルオシノロンアセトニド硝子体内インプラント市場：用途別、2018年-2023年、2024年-2029年
世界のフルオシノロンアセトニド硝子体内インプラント市場：用途別市場シェア、2022年
・病院、クリニック

世界のフルオシノロンアセトニド硝子体内インプラント市場：地域・国別、2018年-2023年、2024年-2029年
世界のフルオシノロンアセトニド硝子体内インプラント市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるフルオシノロンアセトニド硝子体内インプラントのグローバル売上、2018年-2023年
・主要企業におけるフルオシノロンアセトニド硝子体内インプラントのグローバル売上シェア、2022年
・主要企業におけるフルオシノロンアセトニド硝子体内インプラントのグローバル販売量、2018年-2023年
・主要企業におけるフルオシノロンアセトニド硝子体内インプラントのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Auxilium Pharma、 Bausch + Lomb、 EyePoint Pharmaceuticals、 OcuMension

*************************************************************

・調査・分析レポートの概要
フルオシノロンアセトニド硝子体内インプラント市場の定義
市場セグメント
世界のフルオシノロンアセトニド硝子体内インプラント市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のフルオシノロンアセトニド硝子体内インプラント市場規模
世界のフルオシノロンアセトニド硝子体内インプラント市場規模：2022年 VS 2029年
世界のフルオシノロンアセトニド硝子体内インプラント市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのフルオシノロンアセトニド硝子体内インプラントの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のフルオシノロンアセトニド硝子体内インプラント製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：0.18mg、0.19mg、0.59mg
フルオシノロンアセトニド硝子体内インプラントのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック
フルオシノロンアセトニド硝子体内インプラントの用途別グローバル売上・予測

・地域別市場分析
地域別フルオシノロンアセトニド硝子体内インプラント市場規模 2022年と2029年
地域別フルオシノロンアセトニド硝子体内インプラント売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Auxilium Pharma、 Bausch + Lomb、 EyePoint Pharmaceuticals、 OcuMension
...

This research report provides a comprehensive analysis of the Fluocinolone Acetonide Intravitreal Implant market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Fluocinolone Acetonide Intravitreal Implant market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Fluocinolone Acetonide Intravitreal Implant, challenges faced by the industry, and potential opportunities for market players.
The global Fluocinolone Acetonide Intravitreal Implant market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Fluocinolone Acetonide Intravitreal Implant market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Fluocinolone Acetonide Intravitreal Implant market. Additionally, the growing consumer demand present avenues for market expansion.
The global Fluocinolone Acetonide Intravitreal Implant market was valued at US$ 174.5 million in 2022 and is projected to reach US$ 231.9 million by 2029, at a CAGR of 4.2% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Fluocinolone Acetonide Intravitreal Implant market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Fluocinolone Acetonide Intravitreal Implant market.
Market Overview: The report provides a comprehensive overview of the Fluocinolone Acetonide Intravitreal Implant market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 0.18 mg, 0.19 mg), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Fluocinolone Acetonide Intravitreal Implant market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Fluocinolone Acetonide Intravitreal Implant market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Fluocinolone Acetonide Intravitreal Implant market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Fluocinolone Acetonide Intravitreal Implant market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Fluocinolone Acetonide Intravitreal Implant market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Fluocinolone Acetonide Intravitreal Implant market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Fluocinolone Acetonide Intravitreal Implant, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Fluocinolone Acetonide Intravitreal Implant market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Fluocinolone Acetonide Intravitreal Implant market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
0.18 mg
0.19 mg
0.59 mg
Market segment by Application
Hospital
Clinic
Global Fluocinolone Acetonide Intravitreal Implant Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Auxilium Pharma
Bausch + Lomb
EyePoint Pharmaceuticals
OcuMension
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fluocinolone Acetonide Intravitreal Implant, market overview.
Chapter 2: Global Fluocinolone Acetonide Intravitreal Implant market size in revenue and volume.
Chapter 3: Detailed analysis of Fluocinolone Acetonide Intravitreal Implant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fluocinolone Acetonide Intravitreal Implant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fluocinolone Acetonide Intravitreal Implant capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Fluocinolone Acetonide Intravitreal Implant Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fluocinolone Acetonide Intravitreal Implant Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fluocinolone Acetonide Intravitreal Implant Overall Market Size
2.1 Global Fluocinolone Acetonide Intravitreal Implant Market Size: 2022 VS 2029
2.2 Global Fluocinolone Acetonide Intravitreal Implant Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Fluocinolone Acetonide Intravitreal Implant Sales: 2018-2029
3 Company Landscape
3.1 Top Fluocinolone Acetonide Intravitreal Implant Players in Global Market
3.2 Top Global Fluocinolone Acetonide Intravitreal Implant Companies Ranked by Revenue
3.3 Global Fluocinolone Acetonide Intravitreal Implant Revenue by Companies
3.4 Global Fluocinolone Acetonide Intravitreal Implant Sales by Companies
3.5 Global Fluocinolone Acetonide Intravitreal Implant Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Fluocinolone Acetonide Intravitreal Implant Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Fluocinolone Acetonide Intravitreal Implant Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fluocinolone Acetonide Intravitreal Implant Players in Global Market
3.8.1 List of Global Tier 1 Fluocinolone Acetonide Intravitreal Implant Companies
3.8.2 List of Global Tier 2 and Tier 3 Fluocinolone Acetonide Intravitreal Implant Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Fluocinolone Acetonide Intravitreal Implant Market Size Markets, 2022 & 2029
4.1.2 0.18 mg
4.1.3 0.19 mg
4.1.4 0.59 mg
4.2 By Type – Global Fluocinolone Acetonide Intravitreal Implant Revenue & Forecasts
4.2.1 By Type – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2023
4.2.2 By Type – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2024-2029
4.2.3 By Type – Global Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
4.3 By Type – Global Fluocinolone Acetonide Intravitreal Implant Sales & Forecasts
4.3.1 By Type – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2023
4.3.2 By Type – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2024-2029
4.3.3 By Type – Global Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
4.4 By Type – Global Fluocinolone Acetonide Intravitreal Implant Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Fluocinolone Acetonide Intravitreal Implant Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application – Global Fluocinolone Acetonide Intravitreal Implant Revenue & Forecasts
5.2.1 By Application – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2023
5.2.2 By Application – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2024-2029
5.2.3 By Application – Global Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
5.3 By Application – Global Fluocinolone Acetonide Intravitreal Implant Sales & Forecasts
5.3.1 By Application – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2023
5.3.2 By Application – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2024-2029
5.3.3 By Application – Global Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
5.4 By Application – Global Fluocinolone Acetonide Intravitreal Implant Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Fluocinolone Acetonide Intravitreal Implant Market Size, 2022 & 2029
6.2 By Region – Global Fluocinolone Acetonide Intravitreal Implant Revenue & Forecasts
6.2.1 By Region – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2023
6.2.2 By Region – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2024-2029
6.2.3 By Region – Global Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
6.3 By Region – Global Fluocinolone Acetonide Intravitreal Implant Sales & Forecasts
6.3.1 By Region – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2023
6.3.2 By Region – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2024-2029
6.3.3 By Region – Global Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2029
6.4.2 By Country – North America Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2029
6.4.3 US Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.4.4 Canada Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.4.5 Mexico Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2029
6.5.2 By Country – Europe Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2029
6.5.3 Germany Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.4 France Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.5 U.K. Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.6 Italy Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.7 Russia Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.8 Nordic Countries Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.9 Benelux Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2029
6.6.2 By Region – Asia Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2029
6.6.3 China Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.6.4 Japan Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.6.5 South Korea Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.6.6 Southeast Asia Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.6.7 India Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2029
6.7.2 By Country – South America Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2029
6.7.3 Brazil Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.7.4 Argentina Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2029
6.8.3 Turkey Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.8.4 Israel Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.8.5 Saudi Arabia Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.8.6 UAE Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Auxilium Pharma
7.1.1 Auxilium Pharma Company Summary
7.1.2 Auxilium Pharma Business Overview
7.1.3 Auxilium Pharma Fluocinolone Acetonide Intravitreal Implant Major Product Offerings
7.1.4 Auxilium Pharma Fluocinolone Acetonide Intravitreal Implant Sales and Revenue in Global (2018-2023)
7.1.5 Auxilium Pharma Key News & Latest Developments
7.2 Bausch + Lomb
7.2.1 Bausch + Lomb Company Summary
7.2.2 Bausch + Lomb Business Overview
7.2.3 Bausch + Lomb Fluocinolone Acetonide Intravitreal Implant Major Product Offerings
7.2.4 Bausch + Lomb Fluocinolone Acetonide Intravitreal Implant Sales and Revenue in Global (2018-2023)
7.2.5 Bausch + Lomb Key News & Latest Developments
7.3 EyePoint Pharmaceuticals
7.3.1 EyePoint Pharmaceuticals Company Summary
7.3.2 EyePoint Pharmaceuticals Business Overview
7.3.3 EyePoint Pharmaceuticals Fluocinolone Acetonide Intravitreal Implant Major Product Offerings
7.3.4 EyePoint Pharmaceuticals Fluocinolone Acetonide Intravitreal Implant Sales and Revenue in Global (2018-2023)
7.3.5 EyePoint Pharmaceuticals Key News & Latest Developments
7.4 OcuMension
7.4.1 OcuMension Company Summary
7.4.2 OcuMension Business Overview
7.4.3 OcuMension Fluocinolone Acetonide Intravitreal Implant Major Product Offerings
7.4.4 OcuMension Fluocinolone Acetonide Intravitreal Implant Sales and Revenue in Global (2018-2023)
7.4.5 OcuMension Key News & Latest Developments
8 Global Fluocinolone Acetonide Intravitreal Implant Production Capacity, Analysis
8.1 Global Fluocinolone Acetonide Intravitreal Implant Production Capacity, 2018-2029
8.2 Fluocinolone Acetonide Intravitreal Implant Production Capacity of Key Manufacturers in Global Market
8.3 Global Fluocinolone Acetonide Intravitreal Implant Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fluocinolone Acetonide Intravitreal Implant Supply Chain Analysis
10.1 Fluocinolone Acetonide Intravitreal Implant Industry Value Chain
10.2 Fluocinolone Acetonide Intravitreal Implant Upstream Market
10.3 Fluocinolone Acetonide Intravitreal Implant Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fluocinolone Acetonide Intravitreal Implant Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Fluocinolone Acetonide Intravitreal Implant in Global Market
Table 2. Top Fluocinolone Acetonide Intravitreal Implant Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Fluocinolone Acetonide Intravitreal Implant Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Fluocinolone Acetonide Intravitreal Implant Revenue Share by Companies, 2018-2023
Table 5. Global Fluocinolone Acetonide Intravitreal Implant Sales by Companies, (K Units), 2018-2023
Table 6. Global Fluocinolone Acetonide Intravitreal Implant Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Fluocinolone Acetonide Intravitreal Implant Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Fluocinolone Acetonide Intravitreal Implant Product Type
Table 9. List of Global Tier 1 Fluocinolone Acetonide Intravitreal Implant Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fluocinolone Acetonide Intravitreal Implant Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Fluocinolone Acetonide Intravitreal Implant Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Fluocinolone Acetonide Intravitreal Implant Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Fluocinolone Acetonide Intravitreal Implant Sales (K Units), 2018-2023
Table 15. By Type - Global Fluocinolone Acetonide Intravitreal Implant Sales (K Units), 2024-2029
Table 16. By Application – Global Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Fluocinolone Acetonide Intravitreal Implant Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Fluocinolone Acetonide Intravitreal Implant Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Fluocinolone Acetonide Intravitreal Implant Sales (K Units), 2018-2023
Table 20. By Application - Global Fluocinolone Acetonide Intravitreal Implant Sales (K Units), 2024-2029
Table 21. By Region – Global Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Fluocinolone Acetonide Intravitreal Implant Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Fluocinolone Acetonide Intravitreal Implant Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Fluocinolone Acetonide Intravitreal Implant Sales (K Units), 2018-2023
Table 25. By Region - Global Fluocinolone Acetonide Intravitreal Implant Sales (K Units), 2024-2029
Table 26. By Country - North America Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Fluocinolone Acetonide Intravitreal Implant Sales, (K Units), 2018-2023
Table 29. By Country - North America Fluocinolone Acetonide Intravitreal Implant Sales, (K Units), 2024-2029
Table 30. By Country - Europe Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Fluocinolone Acetonide Intravitreal Implant Sales, (K Units), 2018-2023
Table 33. By Country - Europe Fluocinolone Acetonide Intravitreal Implant Sales, (K Units), 2024-2029
Table 34. By Region - Asia Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Fluocinolone Acetonide Intravitreal Implant Sales, (K Units), 2018-2023
Table 37. By Region - Asia Fluocinolone Acetonide Intravitreal Implant Sales, (K Units), 2024-2029
Table 38. By Country - South America Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Fluocinolone Acetonide Intravitreal Implant Sales, (K Units), 2018-2023
Table 41. By Country - South America Fluocinolone Acetonide Intravitreal Implant Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Fluocinolone Acetonide Intravitreal Implant Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Fluocinolone Acetonide Intravitreal Implant Sales, (K Units), 2024-2029
Table 46. Auxilium Pharma Company Summary
Table 47. Auxilium Pharma Fluocinolone Acetonide Intravitreal Implant Product Offerings
Table 48. Auxilium Pharma Fluocinolone Acetonide Intravitreal Implant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Auxilium Pharma Key News & Latest Developments
Table 50. Bausch + Lomb Company Summary
Table 51. Bausch + Lomb Fluocinolone Acetonide Intravitreal Implant Product Offerings
Table 52. Bausch + Lomb Fluocinolone Acetonide Intravitreal Implant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Bausch + Lomb Key News & Latest Developments
Table 54. EyePoint Pharmaceuticals Company Summary
Table 55. EyePoint Pharmaceuticals Fluocinolone Acetonide Intravitreal Implant Product Offerings
Table 56. EyePoint Pharmaceuticals Fluocinolone Acetonide Intravitreal Implant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. EyePoint Pharmaceuticals Key News & Latest Developments
Table 58. OcuMension Company Summary
Table 59. OcuMension Fluocinolone Acetonide Intravitreal Implant Product Offerings
Table 60. OcuMension Fluocinolone Acetonide Intravitreal Implant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. OcuMension Key News & Latest Developments
Table 62. Fluocinolone Acetonide Intravitreal Implant Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 63. Global Fluocinolone Acetonide Intravitreal Implant Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Fluocinolone Acetonide Intravitreal Implant Production by Region, 2018-2023 (K Units)
Table 65. Global Fluocinolone Acetonide Intravitreal Implant Production by Region, 2024-2029 (K Units)
Table 66. Fluocinolone Acetonide Intravitreal Implant Market Opportunities & Trends in Global Market
Table 67. Fluocinolone Acetonide Intravitreal Implant Market Drivers in Global Market
Table 68. Fluocinolone Acetonide Intravitreal Implant Market Restraints in Global Market
Table 69. Fluocinolone Acetonide Intravitreal Implant Raw Materials
Table 70. Fluocinolone Acetonide Intravitreal Implant Raw Materials Suppliers in Global Market
Table 71. Typical Fluocinolone Acetonide Intravitreal Implant Downstream
Table 72. Fluocinolone Acetonide Intravitreal Implant Downstream Clients in Global Market
Table 73. Fluocinolone Acetonide Intravitreal Implant Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Fluocinolone Acetonide Intravitreal Implant Segment by Type in 2022
Figure 2. Fluocinolone Acetonide Intravitreal Implant Segment by Application in 2022
Figure 3. Global Fluocinolone Acetonide Intravitreal Implant Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fluocinolone Acetonide Intravitreal Implant Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2029 (US$, Mn)
Figure 7. Fluocinolone Acetonide Intravitreal Implant Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Fluocinolone Acetonide Intravitreal Implant Revenue in 2022
Figure 9. By Type - Global Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
Figure 11. By Type - Global Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
Figure 12. By Type - Global Fluocinolone Acetonide Intravitreal Implant Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
Figure 15. By Application - Global Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
Figure 16. By Application - Global Fluocinolone Acetonide Intravitreal Implant Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
Figure 20. By Region - Global Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
Figure 21. By Country - North America Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
Figure 22. By Country - North America Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
Figure 23. US Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
Figure 28. Germany Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 29. France Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
Figure 37. China Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 41. India Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
Figure 43. By Country - South America Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
Figure 44. Brazil Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
Figure 48. Turkey Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Fluocinolone Acetonide Intravitreal Implant Revenue, (US$, Mn), 2018-2029
Figure 52. Global Fluocinolone Acetonide Intravitreal Implant Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Fluocinolone Acetonide Intravitreal Implant by Region, 2022 VS 2029
Figure 54. Fluocinolone Acetonide Intravitreal Implant Industry Value Chain
Figure 55. Marketing Channels

※参考情報

フルオシノロンアセトニド硝子体内インプラントは、眼科治療において重要な役割を果たす薬剤供給デバイスです。このインプラントは、慢性の眼疾患に対する持続的な治療を可能にする特性を持ち、特に網膜の炎症や黄斑浮腫に使用されます。

フルオシノロンアセトニドはステロイドの一種であり、強い抗炎症作用を持っています。硝子体内インプラントは、この薬剤を眼球の内部に直接運ぶことができるので、より高い治療効果を期待できます。通常の目薬や注射での投与に比べて、インプラントは薬剤の局所的な濃度を高め、患者の負担を軽減し、治療効果を持続させることができます。

このインプラントの最大の特徴は、持続的な薬剤放出システムです。通常、フルオシノロンアセトニド硝子体内インプラントは、数ヶ月から数年にわたって薬剤を放出します。これにより、患者は定期的な通院や追加の治療を必要とせず、眼の状態を安定させることが可能となります。この特性は特に、網膜疾患や糖尿病性黄斑浮腫などの慢性疾患において有用です。

インプラントの種類には、さまざまな形状やサイズがありますが、フルオシノロンアセトニドの含有量や放出特性に基づいて選択されます。一般的には、眼科医の判断によって、患者の病状や治療方針に応じたインプラントが選ばれます。併せて、手術手技も医師の技術や経験に依存するため、インプラントの導入方法には一定の知識が必要です。

フルオシノロンアセトニド硝子体内インプラントの用途は広範囲にわたります。特に、網膜血管障害や炎症性疾患、加齢黄斑変性などに対して効果があるとされています。特に糖尿病性黄斑浮腫においては、視力の改善や維持に寄与し、患者の生活の質を向上させることが期待されています。また、このインプラントは緑内障の治療にも使われることがあり、眼圧のコントロールにも寄与します。

関連技術としては、インプラントのデザインや製造技術の向上が挙げられます。例えば、放出速度を調節するためのコーティング技術や、生体適合性に優れた材料の研究が進んでいます。これにより、副作用のリスクを低減し、効率的な治療が行えるようになることが期待されています。

さらに、フルオシノロンアセトニド硝子体内インプラントは、患者の個々のニーズに応じたカスタマイズが可能であるため、治療の効果を最大化することができます。研究開発は進行中であり、新たなインプラントの登場や、既存の技術の改良が期待されています。

最後に、フルオシノロンアセトニド硝子体内インプラントは、多くの眼の疾患に対して新たな治療戦略を提供する重要な治療法となっています。今後の技術革新と共に、更なる治療効果の向上や適応症の拡大が期待される分野であり、医療の進展に貢献することが期待されています。すべての患者に対して最適な治療を提供するためには、引き続き多方面からの研究と実践が必要です。患者の生活の質を向上させるために、今後も注目される技術であることは間違いありません。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ フルオシノロンアセトニド硝子体内インプラントのグローバル市場展望 2023年-2029年：0.18mg、0.19mg、0.59mg(Fluocinolone Acetonide Intravitreal Implant Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 人工膵臓インプラントの世界市場見通し2023年-2029年
  • 口腔インプラントシステムのグローバル市場展望 2023年-2029年：ワンピースインプラント、ツーステージインプラント、オッセオインテグレーテッドインプラント
  • 世界の硝子体内注射剤市場予測 2023年-2029年
  • IBSインプラントの世界市場見通し2023年-2029年
  • 人工歯インプラントの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆